Aaron Kwiatkowski obtained both his bachelor’s and master’s degrees in biomedical chemistry from the Johannes Gutenberg University Mainz, Germany, conducting his research in the group of Prof. Tanja Weil at the Max Planck Institute for Polymer Research. His bachelor thesis focused on developing pH-sensitive PET tracers, and his master thesis explored dynamic covalent bioconjugation strategies for biomedical applications. These projects strengthened his interest in chemical biology, bioconjugation chemistry, and the design of functional molecular systems for therapeutic use.

During his studies, Aaron gained experience in protein modification, small-molecule synthesis, bioconjugation, and the analytical characterization of chemical and biomolecular structures using HPLC, MALDI-MS, and NMR spectroscopy. He also worked with cell-penetrating peptides to investigate their potential as delivery platforms.

In November 2025, he began his PhD at the MERLN Institute under the supervision of Dominik Schauenburg and Matt Baker. His project is embedded within the DRIVE-RM consortium, where he contributes to collaborative efforts in regenerative medicine. His research focuses on dynamic covalent chemistry, biomolecule functionalization, and the development of innovative conjugation platforms and responsive materials for therapeutic and diagnostic applications.